Similarly, pregnant women with chemotherapy have an increase in sFlt1/PlGF ratio at the end of pregnancy (37.5 ± 11.3 in PBC-CHT vs. 10.3 ± 1.7 in controls), Figure 3. This evidence concerns the gene PGF and primary biliary cholangitis.